EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

The First Reported Case of an Inherited Pathogenic Variant in DEAF1 From a Parent With Milder Phenotype Provides Evidence of Variable Gene Expressivity of the DEAF1 ‐Associated Vulto‐van Silfout‐de Vries Syndrome ( VSVS )

Kylie Katz, Philip Jensik, Milen Velinov iD

American Journal of Medical Genetics Part A · 2026

DOI: 10.1002/ajmga.70051 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2026. Verfasst von Kylie Katz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetics, Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA. Hauptthemen laut MEDLINE: Intellectual Disability, Transcription Factors, Nuclear Proteins. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIMH NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DEAF1 ‐associated neurodevelopmental disorder (DAND) is a neurodevelopmental spectrum disorder caused by two methods of inheritance: the autosomal dominant intellectual disability syndrome (Vulto‐van Silfout‐de Vries syndrome (VSVS), OMIM #615828), and the autosomal recessive Neurodevelopmental disorder with hypotonia and impaired expressive language with or without seizures (NEDHELS OMIM #615828) (OMIM 617171). All reported cases of VSVS have occurred de novo . In this report, we describe the case of a 2‐year‐old male with a history of autism spectrum disorder and behavioral concerns who was identified to be heterozygous for the c.837C>G (p.C279W) pathogenic variant in DEAF1 . Functional assays demonstrate that the p.C279W variant alters DEAF1's transcriptional repression activity. This variant was also identified in his 26‐year‐old mother, who also has a history of autism and speech delay. To the best of our knowledge, this is the first reported case of the dominant form of DEAF1 ‐associated neurodevelopmental disorder inherited from an affected parent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Intellectual DisabilityTranscription FactorsNuclear ProteinsHumansMalePhenotypeChild, PreschoolDNA-Binding ProteinsFemaleMutationAdultPedigreeSyndromeHeterozygote

Substanzen

Transcription FactorsDEAF1 protein, humanDNA-Binding ProteinsNuclear Proteins

Autor:innen und Institutionen

  • Division of Genetics, Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
  • Division of Molecular and Integrative Physiology, Southern Illinois University School of Medicine, Carbondale, Illinois, USA.

ORCID-Profile: Milen Velinov

Förderung

  • NIH HHS
  • NIMH NIH HHS
  • National Institutes of Health

Zitieren

APA

Katz, K., Jensik, P., & Velinov, M. (2026). The First Reported Case of an Inherited Pathogenic Variant in DEAF1 From a Parent With Milder Phenotype Provides Evidence of Variable Gene Expressivity of the DEAF1 ‐Associated Vulto‐van Silfout‐de Vries Syndrome ( VSVS ). American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmga.70051

Vancouver

Katz K, Jensik P, Velinov M. The First Reported Case of an Inherited Pathogenic Variant in DEAF1 From a Parent With Milder Phenotype Provides Evidence of Variable Gene Expressivity of the DEAF1 ‐Associated Vulto‐van Silfout‐de Vries Syndrome ( VSVS ). American Journal of Medical Genetics Part A. 2026. doi:10.1002/ajmga.70051

BibTeX
@article{Katz2026,
  author = {Katz, Kylie and Jensik, Philip and Velinov, Milen},
  title = {The First Reported Case of an Inherited Pathogenic Variant in DEAF1 From a Parent With Milder Phenotype Provides Evidence of Variable Gene Expressivity of the DEAF1 ‐Associated Vulto‐van Silfout‐de Vries Syndrome ( VSVS )},
  journal = {American Journal of Medical Genetics Part A},
  year = {2026},
  doi = {10.1002/ajmga.70051}
}
Kostenlos starten →